{'fraction_non_alphanumeric': 0.03235294117647059, 'fraction_numerical': 0.011764705882352941, 'mean_word_length': 4.6722222222222225, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Current Management of Multiple Sclerosis

Multiple sclerosis (MS) is a demyelinating disease with an unpredictable course. This course is usually characterized as exacerbating and remitting. The clinical spectrum of the disease is, however, much broader. There are several different courses that MS can take.’.* Benign sensory multiple sclerosis often presents as numbness of an area of the body (FIG. 1 ) . This symptom may then clear or remain but the clinical manifestations of the disease do not appear to progress. This form is more common than one would suspect, however is often difficult to diagnose. It may constitute over 10% of diagnosed cases.3 Benign relapsing-remitting MS presents with mild neurological symptoms and signs that come and go but fail to produce severe disability (FIG. 2). This type of MS has been estimated at 20-30%.4 Chronic progressive MS usually leads to significant disability. The findings slowly and inexorably progress in spite of all measures. This constitutes 10% of MS (FIG.